Authors,Author(s) ID,Title,Year,Source tittle,Cited by,DOI,Country,Document Type,City,Access Type,aggregationType,EID
Bader A.,,MiR-34 - a microRNA replacement therapy is headed to the clinic,2012,Frontiers in Genetics,442,10.3389/fgene.2012.00120,United States,Article,Cambridge,1,Journal,2-s2.0-84869219338
Yang Y.,,MiR-136 promotes apoptosis of glioma cells by targeting AEG-1 and Bcl-2,2012,FEBS Letters,95,10.1016/j.febslet.2012.08.003,China;China,Article,Guangzhou;Guangzhou,1,Journal,2-s2.0-84867572569
Yan G.,,MicroRNA-145 suppresses mouse granulosa cell proliferation by targeting activin receptor IB,2012,FEBS Letters,57,10.1016/j.febslet.2012.06.048,China,Article,Nanjing,0,Journal,2-s2.0-84866627838
Alder H.,,Dysregulation of miR-31 and miR-21 induced by zinc deficiency promotes esophageal cancer,2012,Carcinogenesis,77,10.1093/carcin/bgs204,United States,Article,Columbus,1,Journal,2-s2.0-84865554193
Kurokawa K.,,Role of miR-19b and its target mRNAs in 5-fluorouracil resistance in colon cancer cells,2012,Journal of Gastroenterology,72,10.1007/s00535-012-0547-6,Japan,Article,Tokushima,0,Journal,2-s2.0-84867572383
Yamanaka S.,,Coordinated effects of microRNA-494 induce G<inf>2</inf>/M arrest in human cholangiocarcinoma,2012,Cell Cycle,68,10.4161/cc.21105,United States,Article,Baltimore,1,Journal,2-s2.0-84864391525
Meng S.,,MicroRNA 107 partly inhibits endothelial progenitor cells differentiation via HIF-1β,2012,PLoS ONE,51,10.1371/journal.pone.0040323,China,Article,Shanghai,1,Journal,2-s2.0-84863661526
Feng B.,,MicroRNA-200b reverses chemoresistance of docetaxel-resistant human lung adenocarcinoma cells by targeting E2F3,2012,Cancer,109,10.1002/cncr.26560,China,Article,Nanjing,1,Journal,2-s2.0-84862519692
Cheng W.,,MicroRNA-199a targets CD44 to suppress the tumorigenicity and multidrug resistance of ovarian cancer-initiating cells,2012,FEBS Journal,173,10.1111/j.1742-4658.2012.08589.x,China,Article,Shanghai,0,Journal,2-s2.0-84861193535
Shen L.,,miR-497 induces apoptosis of breast cancer cells by targeting Bcl-w,2012,Experimental and Therapeutic Medicine,86,10.3892/etm.2011.428,China,Article,Shanghai,1,Journal,2-s2.0-84862955506
Borel F.,,Adenosine triphosphate-binding cassette transporter genes up-regulation in untreated hepatocellular carcinoma is mediated by cellular microRNAs,2012,Hepatology,92,10.1002/hep.24682,Netherlands,Article,Amsterdam,0,Journal,2-s2.0-84857439681
Zhu W.,,MiR-497 modulates multidrug resistance of human cancer cell lines by targeting BCL2,2012,Medical Oncology,149,10.1007/s12032-010-9797-4,China,Article,Nanjing,0,Journal,2-s2.0-84862888913
Zhu W.,,miR-200bc/429 cluster modulates multidrug resistance of human cancer cell lines by targeting BCL2 and XIAP,2012,Cancer Chemotherapy and Pharmacology,155,10.1007/s00280-011-1752-3,China,Article,Nanjing,0,Journal,2-s2.0-84859779031
Kasar S.,,Systemic in vivo lentiviral delivery of miR-15a/16 reduces malignancy in the NZB de novo mouse model of chronic lymphocytic leukemia,2012,Genes and Immunity,38,10.1038/gene.2011.58,United States,Article,Newark,1,Journal,2-s2.0-84857785246
Razumilava N.,,miR-25 targets TNF-related apoptosis inducing ligand (TRAIL) death receptor-4 and promotes apoptosis resistance in cholangiocarcinoma,2012,Hepatology,139,10.1002/hep.24698,United States,Article,Rochester,1,Journal,2-s2.0-84856366992
Yamamura S.,,Microrna-34a modulates c-Myc transcriptional complexes to suppress malignancy in human prostate cancer cells,2012,PLoS ONE,96,10.1371/journal.pone.0029722,United States,Article,San Francisco,1,Journal,2-s2.0-84855334413
Turrini E.,,MicroRNA profiling in K-562 cells under imatinib treatment: influence of miR-212 and miR-328 on ABCG2 expression.,2012,Pharmacogenetics and genomics,53,,Germany,Article,Kiel,0,Journal,2-s2.0-85027922548
Garofalo M.,,EGFR and MET receptor tyrosine kinase-altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancers,2012,Nature Medicine,314,10.1038/nm.2577,United States,Article,Columbus,0,Journal,2-s2.0-84855543629
Chim C.,,"Methylation of miR-34a, miR-34b/c, miR-124-1 and miR-203 in Ph-negative myeloproliferative neoplasms",2011,Journal of Translational Medicine,35,10.1186/1479-5876-9-197,Hong Kong,Article,Pokfulam,1,Journal,2-s2.0-81055131632
Wei X.,,Mechanism of EGER-related cancer drug resistance,2011,Anti-Cancer Drugs,9,10.1097/CAD.0b013e32834a149c,Singapore,Review,Singapore City,0,Journal,2-s2.0-80053653017
Bitarte N.,,"MicroRNA-451 is involved in the self-renewal, tumorigenicity, and chemoresistance of colorectal cancer stem cells",2011,Stem Cells,198,10.1002/stem.741,Spain,Article,Pamplona,0,Journal,2-s2.0-80054924979
Becam I.,,Notch-mediated repression of bantam mirna contributes to boundary formation in the drosophila wing,2011,Development,58,10.1242/dev.064774,Spain,Article,Barcelona,1,Journal,2-s2.0-80051533808
Wang Q.,,Alterations of microRNAs in Cisplatin-resistant Human Non-small Cell Lung Cancer Cells (A549/DDP),2011,Experimental Lung Research,65,10.3109/01902148.2011.584263,China,Article,Changsha,0,Journal,2-s2.0-80051761550
Ugras S.,,Small RNA sequencing and functional characterization reveals microrna-143 tumor suppressor activity in liposarcoma,2011,Cancer Research,83,10.1158/0008-5472.CAN-11-0890,United States,Article,New York,1,Journal,2-s2.0-80052207613
Rai K.,,Liposomal delivery of MicroRNA-7-expressing plasmid overcomes epidermal growth factor receptor tyrosine kinase inhibitor-resistance in lung cancer cells,2011,Molecular Cancer Therapeutics,101,10.1158/1535-7163.MCT-11-0220,Japan,Article,Okayama,1,Journal,2-s2.0-80052698948
Haenisch S.,,Down-regulation of ATP-binding cassette C2 protein expression in HepG2 cells after rifampicin treatment is mediated by microRNA-379,2011,Molecular Pharmacology,63,10.1124/mol.110.070714,Germany,Article,Kiel,0,Journal,2-s2.0-79960221018
Gompelmann D.,,Advanced malignant lung disease: What the specialist can offer,2011,Respiration,67,10.1159/000329703,Germany,Article,Heidelberg,1,Journal,2-s2.0-79960705827
Zhu D.,,Aberrant microRNA expression in Chinese patients with chronic lymphocytic leukemia,2011,Leukemia Research,23,10.1016/j.leukres.2010.11.005,China,Article,Nanjing,0,Journal,2-s2.0-79955603055
Lobert S.,,Regulation of β-tubulin isotypes by micro-RNA 100 in MCF7 breast cancer cells,2011,Cytoskeleton,32,10.1002/cm.20517,United States,Article,Jackson,0,Journal,2-s2.0-79959370010
Chen C.,,Novel regulation of nuclear factor-YB by miR-485-3p affects the expression of DNA topoisomerase IIα and drug responsiveness,2011,Molecular Pharmacology,37,10.1124/mol.110.069633,United States,Article,Chicago,0,Journal,2-s2.0-79953021596
Rao X.,,MicroRNA-221/222 confers breast cancer fulvestrant resistance by regulating multiple signaling pathways,2011,Oncogene,262,10.1038/onc.2010.487,United States,Article,Bloomington,1,Journal,2-s2.0-79952281614
Su J.,,Silencing microRNA by interfering nanoparticles in mice,2011,Nucleic Acids Research,54,10.1093/nar/gkq1307,United States,Article,Worcester,1,Journal,2-s2.0-79953676306
Moskwa P.,,MiR-182-Mediated Downregulation of BRCA1 Impacts DNA Repair and Sensitivity to PARP Inhibitors,2011,Molecular Cell,311,10.1016/j.molcel.2010.12.005,United States,Article,Boston,1,Journal,2-s2.0-78651468714
Nardinocchi L.,,HIF-1α antagonizes p53-mediated apoptosis by triggering HIPK2 degradation,2011,Aging,37,10.18632/aging.100254,Italy,Article,Roma,0,Journal,2-s2.0-79958289721
Trang P.,,Systemic delivery of tumor suppressor microRNA mimics using a neutral lipid emulsion inhibits lung tumors in mice,2011,Molecular Therapy,464,10.1038/mt.2011.48,United States;United States,Article,New Haven;New Haven,1,Journal,2-s2.0-79957900919
Valeri N.,,MicroRNA-21 induces resistance to 5-fluorouracil by down-regulating human DNA MutS homolog 2 (hMSH2),2010,Proceedings of the National Academy of Sciences of the United States of America,270,10.1073/pnas.1015541107,Italy;United States,Article,Ferrara;Columbus,1,Journal,2-s2.0-78650500590
Yu Y.,,Context-dependent bidirectional regulation of the muts homolog 2 by transforming growth factor β contributes to chemoresistance in breast cancer cells,2010,Molecular Cancer Research,62,10.1158/1541-7786.MCR-10-0362,China;United States;China,Article,Tianjin;Duarte;Tianjin,1,Journal,2-s2.0-78650423960
Zhu W.,,MiR-181b modulates multidrug resistance by targeting BCL2 in human cancer cell lines,2010,International Journal of Cancer,245,10.1002/ijc.25260,China,Article,Nanjing,1,Journal,2-s2.0-77955619456
Hemida M.G.,,Exploiting the therapeutic potential of microRNAs in viral diseases: Expectations and limitations,2010,Molecular Diagnosis and Therapy,18,10.2165/11539540-000000000-00000,Canada,Review,Vancouver,0,Journal,2-s2.0-78149363346
Li Z.,,MiR-27a modulates MDR1/P-glycoprotein expression by targeting HIPK2 in human ovarian cancer cells,2010,Gynecologic Oncology,142,10.1016/j.ygyno.2010.06.004,China,Article,Wuhan,0,Journal,2-s2.0-77956648184
Shi L.,,MiR-21 protected human glioblastoma U87MG cells from chemotherapeutic drug temozolomide induced apoptosis by decreasing Bax/Bcl-2 ratio and caspase-3 activity,2010,Brain Research,247,10.1016/j.brainres.2010.07.009,China,Article,Zhenjiang,0,Journal,2-s2.0-77956178738
Bader A.,,The promise of microRNA replacement therapy,2010,Cancer Research,413,10.1158/0008-5472.CAN-10-2010,United States,Review,Cambridge,1,Journal,2-s2.0-77956901498
Kota S.,,Cancer therapy via modulation of micro RNA levels: A promising future,2010,Drug Discovery Today,49,10.1016/j.drudis.2010.07.003,France,Review,Paris,0,Journal,2-s2.0-77956453939
Jemal A.,,"Cancer statistics, 2010",2010,CA Cancer Journal for Clinicians,11774,10.3322/caac.20073,United States,Article,Atlanta,0,Journal,2-s2.0-77955635233
Wiggins J.,,Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34,2010,Cancer Research,499,10.1158/0008-5472.CAN-10-0655,United States,Article,Cambridge,1,Journal,2-s2.0-77955022405
Pommier Y.,,DNA topoisomerases and their poisoning by anticancer and antibacterial drugs,2010,Chemistry and Biology,1055,10.1016/j.chembiol.2010.04.012,United States,Review,Bethesda,1,Journal,2-s2.0-77954187741
Fabian M.,,Regulation of mRNA translation and stability by microRNAs,2010,Annual Review of Biochemistry,1759,10.1146/annurev-biochem-060308-103103,Canada,Review,Montreal,0,Book Series,2-s2.0-77953629046
Fujita Y.,,"MiR-148a attenuates paclitaxel resistance of hormone-refractory, drug-resistant prostate cancer PC3 cells by regulating MSK1 expression",2010,Journal of Biological Chemistry,151,10.1074/jbc.M109.079525,Japan,Article,Kakamigahara,1,Journal,2-s2.0-77953486364
Takezawa K.,,Enhanced anticancer effect of the combination of BIBW2992 and thymidylate synthase-targeted agents in non-small cell lung cancer with the T790M mutation of epidermal growth factor receptor,2010,Molecular Cancer Therapeutics,61,10.1158/1535-7163.MCT-09-1009,Japan,Article,Osakasayama,1,Journal,2-s2.0-77953394930
Wu W.,,Up-regulation of fas reverses cisplatin resistance of human small cell lung cancer cells,2010,Journal of Experimental and Clinical Cancer Research,15,10.1186/1756-9966-29-49,China,Article,Chongqing,1,Journal,2-s2.0-77952062240
Chen F.,,Inhibition of c-FLIP expression by miR-512-3p contributes to Taxol-induced apoptosis in hepatocellular carcinoma cells,2010,Oncology Reports,52,10.3892/or-00000784,China,Article,Hangzhou,0,Journal,2-s2.0-77950809880
Liu L.,,Astrocyte Elevated Gene-1 Upregulates Matrix Metalloproteinase-9 and Induces Human Glioma Invasion,2010,Cancer Research,140,10.1158/0008-5472.CAN-09-3838,China;China,Article,Guangzhou;Guangzhou,1,Journal,2-s2.0-77951725566
Song B.,,Molecular mechanism of chemoresistance by miR-215 in osteosarcoma and colon cancer cells,2010,Molecular Cancer,194,10.1186/1476-4598-9-96,United States,Article,Stony Brook,1,Journal,2-s2.0-77951597361
Salton M.,,Involvement of Matrin 3 and SFPQ/NONO in the DNA damage response,2010,Cell Cycle,126,10.4161/cc.9.8.11298,Israel,Article,Ramal Aviv,1,Journal,2-s2.0-77953564663
Liang Z.,,Involvement of miR-326 in chemotherapy resistance of breast cancer through modulating expression of multidrug resistance-associated protein 1,2010,Biochemical Pharmacology,251,10.1016/j.bcp.2009.10.017,United States,Article,Atlanta,0,Journal,2-s2.0-74149092809
Sibley C.,,Novel RNA-based strategies for therapeutic gene silencing,2010,Molecular Therapy,104,10.1038/mt.2009.306,United Kingdom,Review,Oxford,1,Journal,2-s2.0-77649275761
Lanford R.,,Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection,2010,Science,1347,10.1126/science.1178178,United States,Article,San Antonio,0,Journal,2-s2.0-74249112787
Benedettini E.,,Met activation in non-small cell lung cancer is associated with de novo resistance to EGFR inhibitors and the development of brain metastasis,2010,American Journal of Pathology,136,10.2353/ajpath.2010.090863,Italy;United States,Article,Milan;Boston,1,Journal,2-s2.0-77954586493
Garofalo M.,,miR-221&amp;222 Regulate TRAIL Resistance and Enhance Tumorigenicity through PTEN and TIMP3 Downregulation,2009,Cancer Cell,599,10.1016/j.ccr.2009.10.014,United States,Article,Columbus,1,Journal,2-s2.0-70949104622
Kota J.,,Therapeutic microRNA Delivery Suppresses Tumorigenesis in a Murine Liver Cancer Model,2009,Cell,1362,10.1016/j.cell.2009.04.021,United States,Article,Columbus,1,Journal,2-s2.0-66449136951
Shang D.,,Synergy of 5-aza-2′-deoxycytidine (DAC) and paclitaxel in both androgen-dependent and -independent prostate cancer cell lines,2009,Cancer Letters,22,10.1016/j.canlet.2008.12.034,China,Article,Beijing,0,Journal,2-s2.0-63449112539
Pan Y.,,MicroRNA-328 negatively regulates the expression of breast cancer resistance protein (BCRP/ABCG2) in human cancer cells,2009,Molecular Pharmacology,249,10.1124/mol.108.054163,United States,Article,Buffalo,0,Journal,2-s2.0-66849113786
Nitiss J.,,Targeting DNA topoisomerase II in cancer chemotherapy,2009,Nature Reviews Cancer,973,10.1038/nrc2607,United States,Review,"Memphis TN,",0,Journal,2-s2.0-64649090292
Tentori L.,,Recent approaches to improve the antitumor efficacy of temozolomide,2009,Current Medicinal Chemistry,66,10.2174/092986709787002718,Italy,Review,Rome,0,Journal,2-s2.0-62349087854
Fujita Y.,,Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells,2008,Biochemical and Biophysical Research Communications,279,10.1016/j.bbrc.2008.09.086,Japan,Article,Kakamigahara,0,Journal,2-s2.0-54449092239
Bisht S.,,In vivo characterization of a polymeric nanoparticle platform with potential oral drug delivery capabilities,2008,Molecular Cancer Therapeutics,55,10.1158/1535-7163.MCT-08-0476,United States,Article,Baltimore,1,Journal,2-s2.0-57749108568
Miller T.,,MicroRNA-221/222 confers tamoxifen resistance in breast cancer by targeting p27<sup>Kip1</sup>,2008,Journal of Biological Chemistry,607,10.1074/jbc.M804612200,United States,Article,Johnson,1,Journal,2-s2.0-56449092072
Ji Q.,,Restoration of tumor suppressor miR-34 inhibits human p53-mutant gastric cancer tumorspheres,2008,BMC Cancer,332,10.1186/1471-2407-8-266,China;United States,Article,Xi'an;Ann Arbor,1,Journal,2-s2.0-53949090314
To K.,,Regulation of ABCG2 expression at the 3′ untranslated region of its mRNA through modulation of transcript stability and protein translation by a putative microRNA in the S1 colon cancer cell line,2008,Molecular and Cellular Biology,123,10.1128/MCB.00331-08,United States,Article,Bethesda,1,Journal,2-s2.0-50249188925
Zhu H.,,Role of MicroRNA miR-27a and miR-451 in the regulation of MDR1/P-glycoprotein expression in human cancer cells,2008,Biochemical Pharmacology,370,10.1016/j.bcp.2008.06.007,United States,Article,New Brunswick,0,Journal,2-s2.0-49149114863
Lodygin D.,,Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer,2008,Cell Cycle,611,10.4161/cc.7.16.6533,Germany,Article,Planegg,1,Journal,2-s2.0-49749126791
Xia L.,,miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells,2008,International Journal of Cancer,590,10.1002/ijc.23501,China,Article,Xi'an,1,Journal,2-s2.0-44949249814
Youle R.,,The BCL-2 protein family: Opposing activities that mediate cell death,2008,Nature Reviews Molecular Cell Biology,3042,10.1038/nrm2308,United States,Review,Bethesda,0,Journal,2-s2.0-37549048249
Iorio M.V.,,MicroRNA signatures in human ovarian cancer,2007,Cancer Research,1182,10.1158/0008-5472.CAN-07-1936,Italy,Article,Milan,1,Journal,2-s2.0-34548746977
Bommer G.,,p53-Mediated Activation of miRNA34 Candidate Tumor-Suppressor Genes,2007,Current Biology,876,10.1016/j.cub.2007.06.068,United States,Article,Ann Arbor,1,Journal,2-s2.0-34547458550
Friedenson B.,,The BRCA1/2 pathway prevents hematologic cancers in addition to breast and ovarian cancers,2007,BMC Cancer,111,10.1186/1471-2407-7-152,United States,Article,Chicago,1,Journal,2-s2.0-34548415428
He L.,,A microRNA component of the p53 tumour suppressor network,2007,Nature,2086,10.1038/nature05939,United States,Article,Chevy Chase,0,Journal,2-s2.0-34250851115
Engelman J.A.,,MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling,2007,Science,3462,10.1126/science.1141478,United States;United States;United States,Article,Boston;Boston;Boston,0,Journal,2-s2.0-34249075147
Borchert G.M.,,RNA polymerase III transcribes human microRNAs,2006,Nature Structural and Molecular Biology,929,10.1038/nsmb1167,United States,Article,Iowa City,0,Journal,2-s2.0-33845370280
Duncan E.,,"The kinases MSK1 and MSK2 are required for epidermal growth factor-induced, but not tumor necrosis factor-induced, histone H3 Ser<sup>10</sup> phosphorylation",2006,Journal of Biological Chemistry,37,10.1074/jbc.M513333200,United States,Article,Chapel Hill,1,Journal,2-s2.0-33744960216
Calin G.,,Genomics of Chronic Lymphocytic Leukemia MicroRNAs as New Players With Clinical Significance,2006,Seminars in Oncology,122,10.1053/j.seminoncol.2006.01.010,United States,Article,Columbus,0,Journal,2-s2.0-33645960451
Cimmino A.,,miR-15 and miR-16 induce apoptosis by targeting BCL2,2005,Proceedings of the National Academy of Sciences of the United States of America,2704,10.1073/pnas.0506654102,United States,Article,Columbus,1,Journal,2-s2.0-25444520537
Landen C.,,Therapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA delivery,2005,Cancer Research,521,10.1158/0008-5472.CAN-05-0530,United States,Article,Houston,1,Journal,2-s2.0-23044506285
Kansra S.,,Differential effects of estrogen receptor antagonists on pituitary lactotroph proliferation and prolactin release,2005,Molecular and Cellular Endocrinology,89,10.1016/j.mce.2005.04.008,United States,Article,Cincinnati,0,Journal,2-s2.0-20544469804
Ponti D.,,Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties,2005,Cancer Research,1426,10.1158/0008-5472.CAN-05-0626,Italy,Article,Milan,1,Journal,2-s2.0-21344454219
Ozols R.,,Treatment goals in ovarian cancer,2005,International Journal of Gynecological Cancer,194,10.1111/j.1525-1438.2005.15351.x,United States,Conference Paper,Philadelphia,0,Journal,2-s2.0-18844432114
Stupp R.,,Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma,2005,New England Journal of Medicine,11420,10.1056/NEJMoa043330,Switzerland,Article,Lausanne,0,Journal,2-s2.0-20044366163
Kobayashi S.,,EGFR mutation and resistance of non-small-cell lung cancer to gefitinib,2005,New England Journal of Medicine,3054,10.1056/NEJMoa044238,United States,Article,Boston,0,Journal,2-s2.0-13844317894
Meyers M.,,DNA mismatch repair-dependent response to fluoropyrimidine-generated damage,2005,Journal of Biological Chemistry,108,10.1074/jbc.M412105200,United States,Article,Cleveland,1,Journal,2-s2.0-14044264185
Cannistra S.,,Cancer of the ovary,2004,New England Journal of Medicine,1380,10.1056/NEJMra041842,United States,Review,Boston,0,Journal,2-s2.0-19744368302
Lee Y.,,MicroRNA genes are transcribed by RNA polymerase II,2004,EMBO Journal,2798,10.1038/sj.emboj.7600385,South Korea,Article,Seoul,0,Journal,2-s2.0-8144225486
Youn C.,,Oncogenic H-Ras up-regulates expression of ERCC1 to protect cells from platinum-based anticancer agents,2004,Cancer Research,84,10.1158/0008-5472.CAN-04-0348,South Korea,Article,Gwangju,1,Journal,2-s2.0-3142773418
Bartel D.,,"MicroRNAs: Genomics, Biogenesis, Mechanism, and Function",2004,Cell,25016,10.1016/S0092-8674(04)00045-5,United States;United States,Review,Cambridge;Cambridge,1,Journal,2-s2.0-0347444723
Pathak A.K.,,Non small cell lung cancer (NSCLC): current status and future prospects.,Jul-Sep,The Indian journal of chest diseases &amp; allied sciences,23,,India,Review,New Delhi,0,Journal,2-s2.0-16644403826
Lee Y.,,The nuclear RNase III Drosha initiates microRNA processing,2003,Nature,3490,10.1038/nature01957,South Korea,Article,Seoul,0,Journal,2-s2.0-0141843656
Ribic C.M.,,Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer,2003,New England Journal of Medicine,1576,10.1056/NEJMoa022289,Canada,Article,Toronto,0,Journal,2-s2.0-0038002279
Soloaga A.,,MSK2 and MSK1 mediate the mitogen- and stress-induced phosphorylation of histone H3 and HMG-14,2003,EMBO Journal,388,10.1093/emboj/cdg273,United Kingdom,Article,Dundee,0,Journal,2-s2.0-0038182524
Mueller C.,,Regulation of BRCA1 expression and its relationship to sporadic breast cancer,2003,Breast Cancer Research,86,10.1186/bcr557,Canada,Review,Kingston,1,Journal,2-s2.0-0038743059
Longley D.,,5-Fluorouracil: Mechanisms of action and clinical strategies,2003,Nature Reviews Cancer,2681,10.1038/nrc1074,United Kingdom,Review,Belfast,0,Journal,2-s2.0-0038387494
Rubinson D.A.,,"A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference",2003,Nature Genetics,1304,10.1038/ng1117,United States,Article,Cambridge,0,Journal,2-s2.0-0037370498
Calin G.A.,,Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia,2002,Proceedings of the National Academy of Sciences of the United States of America,3725,10.1073/pnas.242606799,United States,Article,Philadelphia,1,Journal,2-s2.0-18744396337
Wiggin G.R.,,MSK1 and MSK2 are required for the mitogen- and stress-induced phosphorylation of CREB and ATF1 in fibroblasts,2002,Molecular and Cellular Biology,334,10.1128/MCB.22.8.2871-2881.2002,United Kingdom,Article,Dundee,1,Journal,2-s2.0-0036193378
Wang Y.,,On the molecular basis of the thermal sensitivity of an Escherichia coli topA mutant,2002,Journal of Biological Chemistry,13,10.1074/jbc.M109436200,United States,Article,Cambridge,1,Journal,2-s2.0-0037059790
Bocangel D.,,Multifaceted resistance of gliomas to temozolomide,2002,Clinical Cancer Research,99,,United States,Article,Galveston,0,Journal,2-s2.0-0036023439
Ashkenazi A.,,Targeting death and decoy receptors of the tumour-necrosis factor superfamily,2002,Nature Reviews Cancer,1040,10.1038/nrc821,United States,Review,San Francisco,0,Journal,2-s2.0-0036598992
Salvesen G.,,IAP proteins: Blocking the road to death's door,2002,Nature Reviews Molecular Cell Biology,1497,10.1038/nrm830,United States,Review,San Diego CA,0,Journal,2-s2.0-0036088471
Krueger A.,,FLICE-inhibitory proteins: Regulators of death receptor-mediated apoptosis,2001,Molecular and Cellular Biology,455,10.1128/MCB.21.24.8247-8254.2001,Germany,Short Survey,Heidelberg,1,Journal,2-s2.0-0035192884
Sampath D.,,Design of new anticancer therapies targeting cell cycle checkpoint pathways,2001,Current Opinion in Oncology,48,10.1097/00001622-200111000-00011,United States,Review,Houston,0,Journal,2-s2.0-0034754073
Reya T.,,"Stem cells, cancer, and cancer stem cells",2001,Nature,7018,10.1038/35102167,United States;United States,Review,Durham;Stanford,0,Journal,2-s2.0-0035499267
Ketterer B.,,A bird's eye view of the glutathione transferase field,2001,Chemico-Biological Interactions,104,10.1016/S0009-2797(01)00277-0,United Kingdom,Short Survey,London,0,Journal,2-s2.0-0035950458
Derynck R.,,TGF-β signaling in tumor suppression and cancer progression,2001,Nature Genetics,1815,10.1038/ng1001-117,United States,Review,San Francisco,0,Journal,2-s2.0-0034785348
Fishel R.,,The selection for mismatch repair defects in hereditary nonpolyposis colorectal cancer: Revising the mutator hypothesis,2001,Cancer Research,131,,United States,Review,Philadelphia,0,Journal,2-s2.0-0035886816
Ketting R.,,Dicer functions in RNA interference and in synthesis of small RNA involved in developmental timing in C. elegans,2001,Genes and Development,1321,10.1101/gad.927801,United States,Article,Cold Spring Harbor,1,Journal,2-s2.0-0035887005
Dean M.,,The human ATP-binding cassette (ABC) transporter superfamily,2001,Genome Research,1307,10.1101/gr.GR-1649R,United States,Review,Frederick,1,Journal,2-s2.0-0034917716
Hutvágner G.,,A cellular function for the RNA-interference enzyme dicer in the maturation of the let-7 small temporal RNA,2001,Science,1975,10.1126/science.1062961,United States,Article,Worcester,0,Journal,2-s2.0-0035800521
Satoh T.,,Expression of glutathione S-transferase pi (GST-pi) in human malignant ovarian tumors,2001,European Journal of Obstetrics and Gynecology and Reproductive Biology,26,10.1016/S0301-2115(00)00473-5,Japan,Article,Ibaraki,0,Journal,2-s2.0-0034987708
Robey R.,,"Overexpression of the ATP-binding cassette half-transporter, ABCG2 (MXR/BCRP/ABCP1), in flavopiridol-resistant human breast cancer cells",2001,Clinical Cancer Research,316,,United States,Article,Bethesda,0,Journal,2-s2.0-0035138482
Borst P.,,A family of drug transporters: The multidrug resistance-associated proteins,2000,Journal of the National Cancer Institute,1443,10.1093/jnci/92.16.1295,Netherlands,Review,Amsterdam,1,Journal,2-s2.0-0034674901
Wang T.,,Paclitaxel-induced cell death: Where the cell cycle and apoptosis come together,2000,Cancer,448,10.1002/1097-0142(20000601)88:11<2619::AID-CNCR26>3.0.CO;2-J,Taiwan,Article,Taipei,1,Journal,2-s2.0-0034212385
Hanahan D.,,The hallmarks of cancer,2000,Cell,19621,10.1016/S0092-8674(00)81683-9,United States,Review,San Francisco,1,Journal,2-s2.0-0034614637
Ishikawa T.,,The human multidrug resistance-associated protein (MRP) gene family: From biological function to drug molecular design,2000,Clinical Chemistry and Laboratory Medicine,44,10.1515/CCLM.2000.130,United States,Article,New York,0,Journal,2-s2.0-0033764825
Nagata S.,,Fas ligand-induced apoptosis,1999,Annual Review of Genetics,638,10.1146/annurev.genet.33.1.29,Japan,Review,Takatsuki,0,Book Series,2-s2.0-0033396491
Oh I.,,"The myb gene family in cell growth, differentiation and apoptosis",1999,Oncogene,383,10.1038/sj.onc.1202839,United States;Canada,Review,Philadelphia;Vancouver,1,Journal,2-s2.0-0033551402
El-Serag H.B.,,Rising incidence of hepatocellular carcinoma in the United States,1999,New England Journal of Medicine,2648,10.1056/NEJM199903113401001,United States;United States,Article,Albuquerque;Albuquerque,0,Journal,2-s2.0-0033545541
Zunino F.,,Molecular mechanisms of resistance to taxanes and therapeutic implications,1999,Drug Resistance Updates,22,10.1054/drup.1999.0108,Italy,Article,Milan,0,Journal,2-s2.0-0033503104
Yvon A.,,Taxol suppresses dynamics of individual microtubules in living human tumor cells,1999,Molecular Biology of the Cell,418,10.1091/mbc.10.4.947,United States,Article,Amherst MA,0,Journal,2-s2.0-0032933622
Miyake K.,,Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: Demonstration of homology to ABC transport genes,1999,Cancer Research,664,,United States,Article,Bethesda,0,Journal,2-s2.0-0032895533
Austin Doyle L.,,A multidrug resistance transporter from human MCF-7 breast cancer cells,1998,Proceedings of the National Academy of Sciences of the United States of America,1811,10.1073/pnas.95.26.15665,United States;United States,Article,Baltimore;Baltimore,1,Journal,2-s2.0-13044249156
Larsen A.,,Cellular resistance to topoisomerase-targeted drugs: From drug uptake to cell death,1998,Biochimica et Biophysica Acta - Gene Structure and Expression,103,10.1016/S0167-4781(98)00140-7,France,Review,Villejuif,0,Journal,2-s2.0-0032189251
Kast C.,,Topology mapping of the amino-terminal half of multidrug resistance- associated protein by epitope insertion and immunofluorescence,1997,Journal of Biological Chemistry,104,10.1074/jbc.272.42.26479,Canada,Article,Montreal,1,Journal,2-s2.0-0030685129
Tsuchida S.,,Usefulness of glutathione S-transferase as a tumor marker,1997,Rinsho byori. The Japanese journal of clinical pathology,5,,Japan,Review,Hirosaki,0,Journal,2-s2.0-0031303049
Jedlitschky G.,,"Transport of glutathione, glucuronate, and sulfate conjugates by the MRP gene-encoded conjugate export pump",1996,Cancer Research,562,,Germany,Article,Heidelberg,0,Journal,2-s2.0-0030063480
Beck J.,,"MDR1, MRP, topoisomerase IIα/β, and cyclin A gene expression in acute and chronic leukemias",1996,Leukemia,30,,Germany,Conference Paper,Tubingen,0,Journal,2-s2.0-0029820407
Hayes J.D.,,The glut athione s-transferase supergene family: Regulation of GST and the contribution of the lsoenzymes to cancer chemoprotection and drug resistance part i,1995,Critical Reviews in Biochemistry and Molecular Biology,3083,10.3109/10409239509083491,United Kingdom,Article,Dundee,0,Journal,2-s2.0-0029561598
Lee R.,,The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14,1993,Cell,8085,10.1016/0092-8674(93)90529-Y,United States,Article,Cambridge,1,Journal,2-s2.0-0027751663
Deffie A.,,"Multifactorial resistance to antineoplastic agents in drug-resistant P388 murine leukemia, Chinese hamster ovary, and human HeLa cells, with emphasis on the role of DNA topoisomerase II.",1992,Biochemistry and cell biology = Biochimie et biologie cellulaire,25,10.1139/o92-055,Canada,Article,Winnipeg,0,Journal,2-s2.0-0026857985
Howie A.,,Glutathione s-transferase and glutathione peroxidase expression in normal and tumour human tissues,1990,Carcinogenesis,245,10.1093/carcin/11.3.451,United Kingdom,Article,Edinburgh,0,Journal,2-s2.0-0025037573
Chung T.,,Characterization and immunological identification of cDNA clones encoding two human DNA topoisomerase II isozymes,1989,Proceedings of the National Academy of Sciences of the United States of America,253,10.1073/pnas.86.23.9431,United States,Article,King of Prussia,1,Journal,2-s2.0-0024372723
Tsai-Pflugfelder M.,,Cloning and sequencing of cDNA encoding human DNA topoisomerase II and localization of the gene to chromosome region 17q21-22,1988,Proceedings of the National Academy of Sciences of the United States of America,365,10.1073/pnas.85.19.7177,United States,Article,Cambridge,1,Journal,2-s2.0-0000676798
Juliano R.,,A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants,1976,BBA - Biomembranes,2619,10.1016/0005-2736(76)90160-7,Canada;Canada,Article,Toronto;Toronto,0,Journal,2-s2.0-33645830172
